-+ 0.00%
-+ 0.00%
-+ 0.00%
Dräger Targets 2030 EBIT Margin of 10%-12%
Share
Listen to the news
Dräger Targets 2030 EBIT Margin of 10%-12%
  • Dräger targets net sales of around EUR 4.5 billion by 2030, up from EUR 3.5 billion in 2025.
  • The EBIT margin is forecast to reach 10%–12%, compared with 6.7% in 2025.
  • Medical division targets include around EUR 2.5 billion in net sales, with an EBIT margin of 7%–9%.
  • The safety division aims for around EUR 2 billion in net sales, with an EBIT margin of 14%–16%.
  • Dividend distributions will remain at least 30% of net profit, implying double-digit dividend growth in coming years.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Drägerwerk AG & Co. KGaA published the original content used to generate this news brief via EQS News (Ref. ID: corporate_2436204_en) on November 18, 2026, and is solely responsible for the information contained therein.

Disclaimer:This article represents the opinion of the author only. It does not represent the opinion of Webull, nor should it be viewed as an indication that Webull either agrees with or confirms the truthfulness or accuracy of the information. It should not be considered as investment advice from Webull or anyone else, nor should it be used as the basis of any investment decision.
What's Trending